69452 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Clinical Oncology and 

Chemoprevention. 

Date: December 1, 2010. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Sharon K. Gubanich, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

1767, gubanics@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28468 Filed 11–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Behavioral Aspects of HIV/AIDS. 

Date: December 3, 2010. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mark P. Rubert, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1775, rubertm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28469 Filed 11–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

November 22, 2010, 1:30 p.m. to 

November 22, 2010, 5 p.m., National 

Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892 which was 

published in the Federal Register on 

October 20, 2010, 75 FR 64736. 

The meeting will be held November 

29, 2010. The meeting time and location 

remain the same. 

The meeting is closed to the public. 

Dated: November 4, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28467 Filed 11–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; B Cell Responses. 

Date: January 11, 2011. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817 

(Telephone Conference Call). 

Contact Person: Lynn Rust, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, NIAID/ 

NIH/DHHS, Room 3120, 6700B Rockledge 

Drive, MSC 7616, Bethesda, MD 20892, 

301–402–3938, lr228v@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 4, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–28459 Filed 11–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of Inspector General 

Solicitation of Information and 

Recommendations for Supplementing 

the Guidance Provided in the Special 

Advisory Bulletin on the Effect of 

Exclusion from Participation in Federal 

Health Care Programs 

AGENCY: Office of Inspector General 

(OIG), HHS. 

ACTION: Notice. 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 69453 

SUMMARY: This notice informs the public 

that the Office of Inspector General 

(OIG) intends to update the Special 

Advisory Bulletin on the Effect of 

Exclusion from Participation in Federal 

Health Care Programs (64 FR 52791; 

September 30, 1999) and solicits input 

from the public for OIG to consider in 

developing the updated bulletin. 

DATES: To assure consideration, public 

comments must be delivered to the 

address provided below by no later than 

5 p.m. on January 11, 2011. 

ADDRESSES: In commenting, please refer 

to file code OIG–115–N. Because of staff 

and resource limitations, we cannot 

accept comments by facsimile (FAX) 

transmission. 

You may submit comments in one of 

three ways (no duplicates, please): 

• Electronically. You may submit 

electronic comments on specific 

recommendations and proposals 

through the Federal eRulemaking Portal 

at http://www.regulations.gov. 

(Attachments should be in Microsoft 

Word, if possible.) 

• By regular, express, or overnight 

mail. You may send written comments 

to the following address: Office of 

Inspector General, Department of Health 

and Human Services, Attention: OIG– 

115–N, Room 5541, Cohen Building, 

330 Independence Avenue, SW., 

Washington, DC 20201. Please allow 

sufficient time for mailed comments to 

be received before the close of the 

comment period. 

• By hand or courier. If you prefer, 

you may deliver, by hand or courier, 

your written comments before the close 

of the comment period to Office of 

Inspector General, Department of Health 

and Human Services, Cohen Building, 

330 Independence Avenue, SW., 

Washington, DC 20201. Because access 

to the interior of the Cohen Building is 

not readily available to persons without 

Federal Government identification, 

commenters are encouraged to schedule 

their delivery with one of our staff 

members at (202) 619–1343. 

For information on viewing public 

comments, please see the 

Supplementary Information section. 

FOR FURTHER INFORMATION CONTACT: 

Patrice Drew, Department of Health and 

Human Services, Office of Inspector 

General, Office of External Affairs, (202) 

619–1368. 

SUPPLEMENTARY INFORMATION: 

Submitting Comments: We welcome 

comments from the public on this 

Special Advisory Bulletin on the Effect 

of Exclusion from Participation in 

Federal Health Care Programs. Please 

assist us by referencing the file code 

OIG–115–N. 

Inspection of Public Comments: All 

comments received before the end of the 

comment period are available for 

viewing by the public. All comments 

will be posted on http:// 

www.regulations.gov as soon as possible 

after they have been received. 

Comments received timely will also be 

available for public inspection as they 

are received at Office of Inspector 

General, Department of Health and 

Human Services, Cohen Building, 330 

Independence Avenue, SW., 

Washington, DC 20201, Monday 

through Friday from 8:30 a.m. to 4 p.m. 

To schedule an appointment to view 

public comments, phone (202) 401– 

2206. 

Background 

The Special Advisory Bulletin on the 

Effect of Exclusion from Participation in 

Federal Health Care Programs contains 

guidance which has proven to be 

extremely important to excluded 

individuals and to all of those in the 

health care industry who are concerned 

with compliance. The health care 

industry and health care professionals 

have now had more than a decade of 

experience with the ramifications of 

exclusion since OIG first published this 

bulletin in 1999. With time it has 

become even more apparent that 

exclusion has a significant impact, not 

only on those who have been excluded 

but also on entities that have employed 

or contracted with excluded persons 

and been faced with liability for 

overpayments and civil monetary 

penalties as a result. As OIG’s 

compliance and enforcement activities 

in this area have increased, many health 

care providers have discovered that they 

employ excluded individuals and have 

self-disclosed to the OIG. Many health 

care providers have also sought to 

design compliance programs that will 

minimize the risk of submitting claims 

to a Federal health care program for 

items or services furnished, ordered, or 

prescribed by an excluded individual. 

In considering the content of the Special 

Advisory Bulletin, OIG is soliciting 

comments, recommendations, and other 

suggestions from concerned parties and 

organizations on how best to 

supplement the guidance provided in 

the Special Advisory Bulletin to address 

relevant issues and to provide useful 

guidance to the industry. For example, 

OIG seeks comments on areas in which 

clarification and further guidance on the 

effect of exclusion may be helpful. 

Dated: November 5, 2010. 

Daniel R. Levinson, 

Inspector General. 

[FR Doc. 2010–28366 Filed 11–10–10; 8:45 am] 

BILLING CODE 4152–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5374–N–21] 

Buy American Exceptions Under the 

American Recovery and Reinvestment 

Act of 2009 

AGENCY: Office of the Assistant 

Secretary for Public and Indian 

Housing, HUD. 

ACTION: Notice. 

SUMMARY: In accordance with the 

American Recovery and Reinvestment 

Act of 2009 (Pub. L. 111–05, approved 

February 17, 2009) (Recovery Act), and 

implementing guidance of the Office of 

Management and Budget (OMB), this 

notice advises that certain exceptions to 

the Buy American requirement of the 

Recovery Act have been determined 

applicable for work using Capital Fund 

Recovery Formula and Competition 

(CFRFC) grant funds. Specifically, an 

exception was granted to the Housing 

Authority of the County of Cook (HACC) 

for the purchase and installation of 

through-the-wall air conditioning units 

and Ground Fault Circuit Interrupter 

(GFCI) outlets for the Riverdale Senior 

Apartments project. 

FOR FURTHER INFORMATION CONTACT: 

Dominique G. Blom, Deputy Assistant 

Secretary for Public Housing 

Investments, Office of Public Housing 

Investments, Office of Public and Indian 

Housing, Department of Housing and 

Urban Development, 451 7th Street, 

SW., Room 4130, Washington, DC, 

20410–4000, telephone number 202– 

402–8500 (this is not a toll-free 

number). Persons with hearing- or 

speech-impairments may access this 

number through TTY by calling the tollfree Federal Information Relay Service 

at 800–877–8339. 

SUPPLEMENTARY INFORMATION: Section 

1605(a) of the Recovery Act provides 

that none of the funds appropriated or 

made available by the Recovery Act may 

be used for a project for the 

construction, alteration, maintenance, or 

repair of a public building or public 

work unless all of the iron, steel, and 

manufactured goods used in the project 

are produced in the United States. 

Section 1605(b) provides that the Buy 

American requirement shall not apply 

in any case or category in which the 

head of a Federal department or agency 

mstockstill on DSKH9S0YB1PROD with NOTICES